ÀǾàǰ¿ë ¶Ñ²±°ú ¸¶°³ ½ÃÀå : Á¦Ç°º°, Àç·áº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Pharmaceutical Caps and Closures Market Report by Product, Material, End User (Pharmaceutical and Biotechnology Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
»óǰÄÚµå : 1675415
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 149 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,339,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,786,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,233,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀǾàǰ¿ë ¶Ñ²±°ú ¸¶°³ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 40¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 77¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³âÀÇ ¼ºÀå·ü(CAGR)Àº 7.22%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ¾Ï, ´ç´¢º´, õ½Ä, ½ÉÇ÷°üÁúȯ µîÀÇ ¸¸¼ºÁúȯ ¹× ±Þ¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ¾ÈÀüÇϰí È¿°úÀûÀÎ Æ÷Àå¿¡ ´ëÇÑ ¿ä±¸ÀÇ Áõ°¡, ¼Ò¾Æ¿ë Æ÷Àå ¼Ö·ç¼ÇÀÇ µµÀÔ µîÀÌ ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

ÀǾàǰ¿ë ĸ Ŭ·ÎÀú´Â ¸ÕÁö¿Í ½À±â, ºÒ¸®ÇÑ ±âÈÄ Á¶°ÇÀ¸·ÎºÎÅÍ ÀǾàǰÀ» º¸È£ÇÏ´Â ±â¹Ð¼ºÀÌ ³ôÀº ¹ÐÆó Á¦Ç°ÀÔ´Ï´Ù. ´Ù¾çÇÑ ±Ý¼Ó Àç·á¿Í °í¹Ðµµ Æú¸®ÇÁ·ÎÇÊ·»(HDPP), Æú¸®¿¡Æ¿·»°ú °°Àº Æú¸®¸Ó·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ȯ°æ ¹× ¹Ì»ý¹°¿¡ ÀÇÇÑ ºÎÆÐ·ÎºÎÅÍ Á¦Ç°À» º¸È£ÇÏ¿© ³»¿ë¹°ÀÇ ½Å¼±µµ¸¦ Àå±â°£ À¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦Ç°ÀÇ ¹Ì°üÀ» Çâ»ó½Ã۰í, ÇÑ Àå¼Ò¿¡¼­ ´Ù¸¥ Àå¼Ò·Î ¿î¼ÛÇÒ ¶§ Ãë±ÞÀÌ Æí¸®ÇÕ´Ï´Ù. ¶ÇÇÑ ¹Ì»ý¹°ÀÇ °ø°ÝÀ̳ª ¿À¿° °¡´É¼ºÀ» ¹æÁöÇÏ¿© Æó±â¹°À» ÃÖ¼ÒÈ­ÇÏ°í Æ÷ÀåµÈ ÀǾàǰÀÇ À¯Åë±âÇÑÀ» ¿¬ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ±× °á°ú, ÀǾàǰ¿ë ¶Ñ²±°ú ¸¶°³¿¡ ´ëÇÑ ¼ö¿ä´Â Àü ¼¼°è¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀǾàǰ¿ë ¶Ñ²±°ú ¸¶°³ ½ÃÀå µ¿Çâ :

ÁÂ½Ä »ýȰ½À°ü, ³ëÀÎ Àα¸ Áõ°¡, °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°üÀ¸·Î ÀÎÇØ °íÇ÷¾Ð, ´ç´¢º´, õ½Ä, ºñ¸¸, COPD, ±Ù°ñ°Ý°è Áúȯ, Ä¡°ú Áúȯ µî ´Ù¾çÇÑ ±Þ¼º ¹× ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Àü ¼¼°è¿¡¼­ ĸ Ŭ·ÎÀú¿Í °°Àº ÀǾàǰ Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÀÚ±ØÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¾ÈÀüÇϰí È¿°úÀûÀÎ Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀǾàǰ¿ë ¶Ñ²±°ú ¸¶°³ ½ÃÀåÀÇ ±â¼ú Çõ½ÅÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ¾î¸°À̵éÀÇ ¾à¹° ¿À³²¿ëÀ» ¹æÁöÇϱâ À§ÇÑ ¾î¸°ÀÌ º¸È£ Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³ÀÎÀÇ ÁöÃâ ´É·Â Áõ°¡¿Í º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ¹× ±âŸ ÀÇ·á ¼¾ÅÍÀÇ È®´ë·Î ÀÎÇØ Àü ¼¼°è¿¡¼­ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾÷°è ÅõÀÚÀÚµéÀÌ Ã·´Ü Á¦Á¶ ±â¼úÀ» Ȱ¿ëÇÏ¿© Á¤¹ÐÇϰí È¿À²ÀûÀÎ °æ·® ĸ Ŭ·ÎÀú¸¦ Á¦Á¶ÇÏ´Â µ¥¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå Àü¸ÁÀº ±àÁ¤ÀûÀÔ´Ï´Ù. À̿ʹ º°µµ·Î, ÇÃ¶ó½ºÆ½À¸·Î Á¦Á¶µÈ ĸ Ŭ·ÎÀú´Â °æÁ¦ÀûÀÌ°í ³»±¸¼ºÀÌ ¶Ù¾î³ª¸ç ºÎ½Ä¿¡ °­ÇϹǷΠÁ¦¾à ¾÷°è¿¡¼­ Å« ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ÃÖÁ¾»ç¿ëÀÚÀÇ ¿ä±¸ »çÇ×À» ÃæÁ·½Ã۱â À§ÇØ ³»È­ÇмºÀÌ ¿ì¼öÇÑ ´Ù¾çÇÑ ¸ð¾ç°ú Å©±âÀÇ ¸ÂÃãÇü Á¦Ç°À» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯°æ¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Á¦Ç° °³¹ß ºñ¿ëÀ» ÁÙÀ̱â À§ÇØ ÀçȰ¿ë °¡´ÉÇÑ Àç·á¿Í »ýºÐÇØ¼º Àç·á¸¦ »ç¿ëÇÑ Áö¼Ó°¡´ÉÇÑ Å¬·ÎÀú ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå °³¹ßÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ÀǾàǰ¿ë ¶Ñ²±°ú ¸¶°³ ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

Á¦7Àå ½ÃÀå ³»¿ª : Àç·áº°

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦10Àå ÃËÁø¿äÀΡ¤¾ïÁ¦¿äÀΡ¤±âȸ

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global pharmaceutical caps and closures market size reached USD 4.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 7.22% during 2025-2033. The growing prevalence of chronic and acute conditions, such as cancer, diabetes, asthma, and cardiovascular diseases, rising need for safe and effective packaging, and the introduction of child-proof packaging solution represent some of the key factors driving the market.

Pharmaceutical caps and closures are air-tight sealing products that protect pharmaceutical items from dust, moisture, and unfavorable climatic conditions. They are made up of different metallic materials and polymers, such as high-density polypropylene (HDPP) and polyethylene. They help keep the content fresh for an extended period by protecting products from environmental and microbiological spoilage. They also enhance product aesthetics and make handling convenient during transportation from one place to another. In addition, they assist in minimizing wastage and increasing the shelf-life of packed medicines by averting the chances of microbial attacks and contamination. As a result, the demand for pharmaceutical caps and closures is increasing across the globe.

Pharmaceutical Caps and Closures Market Trends:

Due to sedentary lifestyles, rising geriatric population, and unhealthy dietary patterns, there is an increase in the prevalence of various acute and chronic conditions, such as hypertension, diabetes, asthma, obesity, COPD, musculoskeletal disorders, and dental problems. This represents one of the key factors catalyzing the demand for pharmaceutical packaging solutions like caps and closures across the globe. The escalating demand for safe and effective packaging solutions is also encouraging innovations in the pharmaceutical caps and closures market. Along with this, the rising need for child-proof packaging solutions to prevent kids from accidental consumption is another major factor supporting the growth of the market. Furthermore, the demand for pharmaceutical products is increasing worldwide with the increasing expenditure capacity of individuals and the expansion of hospitals, ambulatory surgical centers (ASCs), and other healthcare centers. Moreover, rising focus of industry investors on utilizing advanced manufacturing techniques for producing lightweight caps and closures with high precision and efficiency is offering a favorable market outlook. Apart from this, caps and closures manufactured with plastic are gaining immense traction in the pharmaceutical industry as they are economical, durable, and resistant to corrosion. Furthermore, leading market players are developing customized products in different shapes and sizes with superior chemical resistance properties to meet end-user requirements. They are also focusing on the development of sustainable closure solutions made from recyclable or biodegradable materials to reduce the environmental impact and product development costs, which is anticipated to propel the market growth.

Key Market Segmentation:

Product Insights:

Material Insights:

End User Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Pharmaceutical Caps and Closures Market

6 Market Breakup by Product

7 Market Breakup by Material

8 Market Breakup by End User

9 Market Breakup by Region

10 Drivers, Restraints, and Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â